Ergebnis der Suchanfrage nach @suche@@r@Borna@dokument

Grünenthal Group

Grünenthal appoints Prof. Dr. Uli Brödl as Chief Scientific Officer

BIAL SA

BIAL Announces First Patient Out in its Phase 2 Clinical Trial of BIA 28-6156 - a Novel Therapy for GBA1 Parkinson's Disease

Porto, Portugal (ots/PRNewswire) - BIAL, a hundred-year-old innovation-driven biopharmaceutical company focused on neurosciences and rare diseases, announced that the first patient has completed the full dose regimen in the ACTIVATE Phase 2 study. BIA 28-6156 is a first-in-class, small molecule for once-daily oral ...

Norgine

Norgine submits Marketing Authorisation Application to the European Medicines Agency for eflornithine (difluoromethylornithine [DFMO]) in high-risk neuroblastoma

London (ots/PRNewswire) - Back to media releases Next media release Norgine today announced that it completed its marketing authorisation application filing to European Medicines Agency (EMA) for eflornithine in high-risk neuroblastoma (HRNB). This follows the submissions in April 2024, via Project Orbis, in ...

LAUDA DR. R. WOBSER GMBH & CO. KG

Dr. Stefanie Krieger Managing Director of LAUDA Medical

LAUDA DR. R. WOBSER GMBH & CO. KG

Antonio Manconi Ten Years With LAUDA Italia

INFOSYS

Infosys Strengthens Strategic Collaboration with Google Cloud to Boost Enterprise AI Innovation, Establishes Center of Excellence

Bengaluru, India (ots/PRNewswire) - Leveraging Infosys Topaz and Google Cloud technology, the center of excellence will foster co-innovation to deliver transformative AI-powered solutions Infosys (NSE: INFY), (BSE: INFY), (NYSE: INFY), a global leader in next-generation digital services and consulting, today ...

LAUDA DR. R. WOBSER GMBH & CO. KG

LAUDA World Market Leader for the Ninth Time

ONEKEY GmbH

20 Percent of Companies Fail to Conduct Cybersecurity Audits

20 Percent of Companies Fail to Conduct Cybersecurity Audits Building Cybersecurity Awareness: Empowering Workforces to Tackle Cyberattacks and Threats Duesseldorf, December 11 2024 – 40 percent of industrial companies in Germany provide regular cybersecurity education and training for their employees, while 27 percent include cybersecurity rules and procedures in their employee handbooks and company policies. “That ...

Technische Universität München

Removing hazardous PFAS chemicals from drinking water

TECHNICAL UNIVERSITY OF MUNICH NEWS RELEASE TUM researchers develop highly effective filter material Removing hazardous PFAS chemicals from drinking water - Metal-organic framework compounds made of zirconium carboxylate as filters - Large-scale use in practice still to come - Contaminated sites caused by PFAS will be with us for several generations ahead The chemicals known as PFAS are considered a severe threat to ...

ARTTIC Innovation GmbH

Reminder: canSERV Call for Service Provision "Training the Next Generation of Cancer Researchers"

ONEKEY GmbH

Experts Warn of Cybersecurity Risks in Open-Source Software

Experts Warn of Cybersecurity Risks in Open-Source Software Manufacturers of connected devices, machines, and systems that use open-source software face an exceptionally high risk. Duesseldorf, 21 November 2024 – Manufacturers of connected devices, machines, and systems must be particularly vigilant when using open-source software in their products under the new EU Cyber Resilience Act (CRA). Although open-source ...

DHL Group

PM: Globalisierung bleibt auf Rekordniveau, trotz geopolitischer Spannungen und Unsicherheit / PR: Globalization remains at a record level, despite geopolitical tensions and uncertainties

ARTTIC Innovation GmbH

New Project DCDYNAMIC Advances Cable Technology for Greener Power Grid

ARTTIC Innovation GmbH

Last Call for canSERV Third Open Call Funding

LAUDA DR. R. WOBSER GMBH & CO. KG

4

LAUDA Doubles Production Area in China

ONEKEY GmbH

Report Reveals: Industry Exposes Itself to Cybersecurity Risks

Report Reveals: Industry Exposes Itself to Cybersecurity Risks - The digitalisation of manufacturing and logistics introduces unknown software vulnerabilities that hackers can exploit. - ONEKEY’s “OT+IoT Cybersecurity Report” reveals: Smart factories are often insufficiently protected. Duesseldorf, November 7 2024 – German industry is increasingly exposing itself to security vulnerabilities due to the ongoing ...

LAUDA DR. R. WOBSER GMBH & CO. KG

40th work anniversary at the world market leader

LAUDA DR. R. WOBSER GMBH & CO. KG

LAUDA honors Rainer Deinert for 45 years of company loyalty

ONEKEY GmbH

Cyber Resilience Act Passed – A Paradigm Shift in Product Cybersecurity

Cyber Resilience Act Passed – A Paradigm Shift in Product Cybersecurity Jan Wendenburg: “The Cyber Resilience Act was passed by the EU Council on October 10th, making cybersecurity mandatory for all manufacturers. Connected devices must be designed to remain protected against cyberattacks with up-to-date software throughout their entire lifecycle.” Duesseldorf, ...

INFOSYS

Infosys Unveils Small Language Models - Infosys Topaz BankingSLM and Infosys Topaz ITOpsSLM - Built on NVIDIA AI Stack

Bengaluru, India (ots/PRNewswire) - - The small language models will be integrated into products and services as part of Infosys Topaz offerings to provide enterprises with a foundation to build their specialized models - Infosys' dedicated center of excellence for NVIDIA serves as a centralized hub for AI-powered ...

INFOSYS

Infosys Expands Strategic Collaboration with Meta: Unveils Center of Excellence to Drive Enterprise AI Innovation through Open Source

Bengaluru, India (ots/PRNewswire) - Leverages Meta's Llama stack to democratize access to AI technology Infosys (NSE: INFY), (BSE: INFY), (NYSE: INFY), a global leader in next-generation digital services and consulting, today strengthened its collaboration with Meta, a multinational technology company, to drive ...

LAUDA DR. R. WOBSER GMBH & CO. KG

Dr. Marc Stricker with LAUDA for ten years

Grünenthal Group

First participants enrolled in first-in-human Phase I clinical trial with nociceptin (NOP) receptor agonist

Aachen, Germany (ots) - Today, Grünenthal announced that the first participants have been enrolled in a first-in-human Phase I clinical trial for a nociceptin (NOP) receptor agonist. The trial will include 90 healthy volunteers and aims to demonstrate a favourable safety and tolerability profile and to confirm the ...

Epitomee Medical

Epitomee Medical to Present the Epitomee Breakthrough Oral Delivery Platform at PODD 2024 Conference

Caesarea, Israel (ots/PRNewswire) - Epitomee Medical Ltd. (TASE: EPIT) announces today that the company leadership intends to present Epitomee's Oral Delivery of Biologics Platform at the 14th Annual PODD Conference - Partnership Opportunities in Drug Delivery, taking place in Boston, MA, October 28-29, 2024. ...